Central Garden & Pet Posts Record Q2, Confirming Margin Recovery

What happened

Central Garden & Pet reported record fiscal Q2 2026 results with higher sales, expanded operating margins, and increased EPS year-over-year, driven by consistent execution of its Cost and Simplicity initiatives. The performance validates the margin expansion thesis central to the DeepValue BUY case, which noted the stock's 17% pullback and undemanding 13.5x P/E. However, the release lacked detail on Garden segment performance, which remains exposed to weather and distribution headwinds. The company's scaled pet and garden brand portfolio and distribution network provide a durable moat, but customer concentration (top five ~54% of sales) and cyclical garden headwinds warrant monitoring. Overall, the results support the view that fundamental improvements are taking hold.

Implication

The record Q2 reinforces the BUY thesis that Central Garden & Pet's Cost and Simplicity program is driving sustainable operating leverage, and the 13.5x P/E remains cheap versus a ~$123 DCF fair value. However, investors must monitor garden seasonality, key account concentration (top 5 customers ~54% of sales), and any reversal in margin momentum. The stock's low valuation and strong free cash flow generation provide downside protection, but sustained execution is needed to close the valuation gap.

Thesis delta

The Q2 results provide high-conviction evidence that the margin recovery thesis is materializing faster than expected, shifting the narrative from 'potential' to 'delivery.' The investment case now rests on sustained execution and garden normalization, not proof of concept.